https://doi.org/10.4081/reumatismo.2011.171
Splenic tuberculosis in a patient with ankylosing spondylitis treated with adalimumab
Submitted: 9 November 2011
Accepted: 9 November 2011
Published: 9 November 2011
Accepted: 9 November 2011
Abstract Views: 938
PDF: 722
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Authors
How to Cite
Azevedo, V., Paiva, E., Tosin, T., Ferreira, A., Ferreira, A., & Fernandes, M. (2011). Splenic tuberculosis in a patient with ankylosing spondylitis treated with adalimumab. Reumatismo, 63(3), 171–174. https://doi.org/10.4081/reumatismo.2011.171
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
Similar Articles
- L.G. De Filippis, A. Balestrieri, P. Furfari, A. Caliri, A. Africa, G. Bagnato, Muscle activation patterns and gait biomechanics in patients with ankylosing spondylitis , Reumatismo: Vol. 58 No. 2 (2006)
- M. Ferrito, G. Cincinelli, M. Manara, R. Di Taranto, E.G. Favalli, R. Caporali, Retention rate of tumor necrosis factor inhibitors, anti-interleukin 17, and anti-interleukin 12/23 drugs in a single-center cohort of psoriatic arthritis patients , Reumatismo: Vol. 75 No. 2 (2023)
- M. Gutierrez, A. Becciolini, C. Bertolazzi, L. Di Geso, M. Tardella, A. Ariani, E. Filippucci, W. Grassi, Polyarthritis flare in patient with ankylosing spondylitis treated with infliximab , Reumatismo: Vol. 62 No. 3 (2010)
- A. Cauli, G. Dessole, P.P. Nurchis, A. Vacca, A. Mameli, P. Garau, R. Pala, G. Passiu, A. Mathieu, The role of HLA-B27 molecules in the pathogenesis of ankylosing spondylitis , Reumatismo: Vol. 54 No. 3 (2002)
- Giuseppe D'Alessandro, Maria Rosaria Bianco, Spiridon Politis, Celestino Ferrandina, Giuseppe Rossi, Emanuele Altomare, Case report: AREB in a patient with rheumatoid arthritis treated with methotrexate and infliximab , Reumatismo: Vol. 58 No. 1 (2006)
- A. Calligaro, A. Hoxha, A. Ruffatti, L. Punzi, Are biological drugs safe in pregnancy? , Reumatismo: Vol. 66 No. 4 (2014)
- S. Parisi, M. Bruzzone, C. Centanaro Di Vittorio, A. Laganà, C.L. Peroni, E. Fusaro, Efficacy of bosentan in the treatment of Raynaud’s phenomenon in patients with systemic sclerosis never treated with prostanoids , Reumatismo: Vol. 65 No. 6 (2013)
- Ombretta Di Munno, Andrea Delle Sedie, Glucocorticoid-induced osteoporosis and rheumatic diseases. Pathogenesis, prevention and treatment , Reumatismo: Vol. 58 No. 1 (2006)
- N. Belfeki, M. Smiti Khanfir, F. Said, A. Hamzaoui, T. Ben Salem, I. Ben Ghorbel, M. Lamloum, M.H. Houman, Successful treatment of refractory adult onset Still’s disease with rituximab , Reumatismo: Vol. 68 No. 3 (2016)
- M.E. Nieddu, L. Menza, F. Baldi, B. Frediani, R. marcolongo, Efficacy of Cellfood®’s therapy (deutrosulfazyme) in fibromyalgia , Reumatismo: Vol. 59 No. 4 (2007)
<< < 4 5 6 7 8 9 10 11 12 13 > >>
You may also start an advanced similarity search for this article.
